 |
 |
Sanofi to acquire US medical device company Pluromed to expand in biosurgery
16 March 2012
|
|
|
|
Lupin, Sanofi-Aventis Philippines in strategic agreement
05 September 2011
|
|
|
Sanofi plans Rs450-cr OTC deal with Universal Medicare
23 August 2011
|
| | |
|
|
Sanofi to sell skincare business to Canada's Valeant Pharmaceuticals for $425 mn
11 July 2011
|
|
|
Sanofi-Aventis shortens name to Sanofi
07 May 2011
|
|
|
Merck, Sanofi Pasteur start Phase-3 trials of paediatric combination vaccine in US
23 April 2011
|
|
|
Sanofi-Aventis seals Genzyme deal with $20.1-bn takeover offer
17 February 2011
|
|
|
Sanofi-Aventis, Genzyme in talks to structure $80 per share deal
08 January 2011
|
|
|
Sanofi-Aventis extends Genzyme offer, terms unchanged
13 December 2010
|
|
|
Aventis to exit Chiron JV with Novartis, with Rs105-crore stake sale
13 December 2010
|
|
|
Genzyme counters Sanofi’s hostile takeover with 2011 earning projections
23 October 2010
|
|
|
Sanofi-Aventis goes hostile with $18.5-bn Genzyme bid
04 October 2010
|
|
|
Sanofi Aventis reportedly raises offer to $71 per share
09 September 2010
|
|
|
Genzyme board rejects Sanofi-Aventis $18.5-billion takeover offer
31 August 2010
|
|
|
Sanofi-Aventis reveals $18.5-billion offer for Genzyme
30 August 2010
|
|
|
Genzyme begins takeover talks with Sanofi-Aventis
03 August 2010
|
|
|
Glaxo follows Sanofi-Aventis to biotech major Genzyme
26 July 2010
|
|
|
Sanofi-Aventis targets troubled Genzyme Corp for takeover
24 July 2010
|
|
|
Sanofi-Aventis gearing to make US acquisition worth $20 billion: report
03 July 2010
|
|
|
Sanofi-Aventis to buy US oncology products firm TargeGen for $560 million
30 June 2010
|
|
|
Sanofi-Aventis signs global licensing pact with Metabolex for Type II diabetes drug
25 June 2010
|
|
|
Sanofi-Aventis signs $750-million microRNA therapeutics deal with Regulus
22 June 2010
|
|
|
Sanofi Aventis signs antibody research deal with Vivalis SA
09 June 2010
|
|
|
Sanofi-Aventis signs $398-million cancer drug license deal with Ascenta Therapeutics
04 June 2010
|
|
|
Sanofi-Aventis and Nichi-Iko Pharmaceutical to form generic drug JV
29 May 2010
|
|
|
Glenmark in $325-million drug deal with Sanofi-Aventis
03 May 2010
|
|
|
US court bans Sun Pharma's generic equivalent of Sanofi's eloxatin
24 April 2010
|
|
|
Sanofi-Aventis in $335-million diabetes drug deal with CureDM
08 April 2010
|
|
|
Sanofi-Aventis settles patent infringement suit with generic drug manufacturers
03 April 2010
|
|
|
Sanofi-Aventis concludes Chattem acquisition
13 March 2010
|
|
|
Sanofi-Aventis commences tender offer for Chattem
11 January 2010
|
|
|
Sanofi-aventis to acquire Chattem for $1.9 billion
21 December 2009
|
|
|
Sanofi-Aventis signs drug localisation pact with Russia
28 November 2009
|
|
|
Sanofi-Aventis expands Regeneron research deal to $1 billion
11 November 2009
|
|
|
AstraZeneca says its new anti-clotting drug better than Plavix
31 August 2009
|
|
|
Sanofi-Aventis to acquire Merck's Merial stake for $4 billion
30 July 2009
|
|
|
Sanofi-Aventis to acquire Shantha Biotech for Rs3,757 crore
27 July 2009
|
|
|
Sanofi’s diabetes drug may increase cancer risk: European study
27 June 2009
|
|
|
Sanofi-Aventis inks cancer drug research deal with Exelixis
29 May 2009
|
|
|
Sanofi to buy US cancer drug firm for about $500 million
15 April 2009
|
|
|
Glaxo, Sanofi in talks for Shanta Biotch takeover
30 March 2009
|
|
|
PPF ends opposition to Zentiva sale; Sanofi takeover likely
11 February 2009
|
|
|
Sanofi settles Allegra, Nasacort patent suits with Teva, Barr
20 November 2008
|
|
|
French pharma Sanofi-Aventis acquires Zentiva for $2.6 billion
23 September 2008
|
|
|
Sanofi-aventis to acquire Symbion Holdings for $544 million
21 July 2008
|
|
|
Zentiva turns down PPF subsidiary Anthiarose as Sanofi makes rival bid
23 June 2008
|
|
|
Top two shareholders, including Sanofi-Aventis, launch competing bids for Czech drugmaker Zentiva
19 June 2008
|
|
|
Sanofi commits 60 million doses of H5N1 vaccine for WHO global H5N1 vaccine stockpile
16 June 2008
|
|
|
French drug giant Sanofi-Aventis opens R&D centre in Goa
05 December 2007
|
|
|
Dr Reddy's in discussions with Sanofi-Aventis to settle Plavix litigation
22 March 2006
|
